US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: Healthcare Innovator Poised for 32% Upside

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector, has carved a niche for itself within the medical devices industry, providing cutting-edge solutions for both prevention and recovery,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Pioneer with Robust Revenue Growth and Promising Pipeline

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands at the forefront of the biotechnology sector with an impressive market capitalization of $8.51 billion. The company, headquartered in Newark, California, has carved out..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 77% Potential Upside in the Healthcare Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to cancer treatment through Tumor Treating Fields (TTFields). Headquartered in Baar,..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Evaluating a Robust 7.43% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a key player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, commands a significant presence in the global biopharmaceutical landscape...

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 7.52% Potential Upside in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.45 billion, Envista stands as..

Haemonetics Corporation (HAE) Stock Analysis: Strong Buy Ratings Propel Healthcare Innovator Amid 87.90 Target Price

Haemonetics Corporation (NYSE: HAE), a leader in medical technology specializing in blood management solutions, is capturing the attention of investors with its robust growth potential and favorable market position. Trading..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Analyzing the 13.85% Potential Upside

LifeStance Health Group, Inc. (LFST), a prominent player in the U.S. healthcare sector, has been making waves in the outpatient mental health services industry. With a market capitalization of $4.02..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A 25% Upside in Biotech Innovation

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors as it navigates the dynamic landscape of biotechnology. With a focus on developing RNA interference-based therapies for intractable diseases,..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating Its 5.04% Dividend Yield Amidst Market Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a notable player in the healthcare sector, particularly in the medical instruments and supplies industry, has been generating interest among investors with its compelling dividend..

ImmunityBio, Inc. (IBRX) Stock Analysis: Assessing a 78% Potential Upside in Cutting-Edge Immunotherapy

ImmunityBio, Inc. (NASDAQ: IBRX) is catching the eyes of investors with its promising strides in the biotechnology sector, focusing on next-generation immunotherapies. With a market capitalization of $7.49 billion, this..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 113% Upside Potential

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a noteworthy player in the biotechnology sector, focused on developing treatments for rare and ultra-rare genetic diseases. With a market capitalization of $2.46..

RadNet, Inc. (RDNT) Investor Outlook: A 40% Potential Upside in Healthcare Imaging

RadNet, Inc. (NASDAQ: RDNT), a prominent name in the healthcare sector, specifically in diagnostics and research, has been capturing investor attention with its substantial growth potential and innovative approach to..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 49% Upside Potential in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a notable player in the biotechnology sector, is drawing considerable attention from investors due to its promising pipeline of RNA-targeted therapeutics and gene therapies aimed..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Look at Strong Analyst Ratings and Significant Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the intersection of hope and innovation in the biotechnology sector, focusing on therapeutic solutions for rare neuroendocrine diseases. With a robust market cap..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 32.3% Revenue Growth Amidst a Complex Valuation

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has garnered significant attention from investors due to its robust revenue..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a Promising 12.70% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has been making waves in the biotechnology sector with its innovative approach to tackling genetic diseases. As a commercial-stage company, Krystal Biotech focuses on developing..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Evaluating the Growth Potential Amid Robust Revenue Expansion

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector, presenting significant opportunities for investors focused on innovative healthcare solutions. The company, headquartered in San Diego, California, specializes..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 0.32% Dividend Yield Amidst a Mixed Performance Landscape

Bruker Corporation (NASDAQ: BRKR), renowned for its innovative advancements in scientific instruments and analytical solutions, stands as a notable player within the healthcare sector, specifically in the medical devices industry...

BrightSpring Health Services (BTSG) Stock Analysis: 31% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare industry, not only for its comprehensive services but also for its promising investment potential. With a market capitalization of $11.72..

Nuvalent, Inc. (NUVL) Stock Analysis: A $9.79 Billion Biotech Game-Changer Facing Analyst Consensus

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector with its innovative approach to addressing treatment resistance in cancer therapies. With a market capitalization of $9.79 billion and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds